Famotidin 20-SL

Hlavné informácie

  • Názov lieku:
  • Famotidin 20-SLtbl flm 500x20 mg
  • Forma lieku:
  • tbl flm 500x20 mg
  • Spôsob podávania:
  • perorálne použitie
  • Počet v balení:
  • tbl flm 500x20 mg
  • Typ predpisu:
  • Viazaný na lekársky predpis
  • Použiť pre:
  • ľudia
  • Typ lieku:
  • alopatickej drog

Dokumenty

Lokalizácia

  • K dispozícii v:
  • Famotidin 20-SLtbl flm 500x20 mg
    Slovensko
  • Jazyk:
  • slovenčina

Terapeutická informácie

  • Terapeutické skupiny:
  • 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV)

Ďalšie informácie

Stav

  • Zdroj:
  • SIDC
  • Dátum Autorizácia:
  • 01-06-1999
  • Posledná aktualizácia:
  • 09-08-2016

Písomná informácia pre používateľov

Písomná informácia pre užívateľa 

Informácia o použití, čítajte pozorne! 

Famotidin 20-SL 

Famotidin 40-SL 

(famotidinum)  

filmom obalené tablety 

Držiteľ rozhodnutia o registrácii 

SLOVAKOFARMA, a. s., Hlohovec, Slovenská republika 

Zloženie lieku 

Liečivo: 

famotidinum (famotidín) 20 alebo 40 mg v jednej tablete 

Pomocné látky: 

saccharum lactis monohydricum (monohydrát laktózy), cellulosum microcrystallisatum 

(mikrokryštalická celulóza), maydis amylum (kukuričný škrob), polyvidonum K 30 

(povidón), silicii dioxidum hydratum (hydratovaný oxid kremičitý), croscarmellosum 

natricum (sodná soľ kroskarmelózy), magnesii stearas (stearan horečnatý), hypromellosum 

(hypromelóza), hydroxypropylcellulosum (hydroxypropylcelulóza), titanii dioxidum E 171 

(oxid titaničitý), talcum (mastenec) 

Farmakoterapeutická skupina 

antiulcerózum, blokátor histamínových H2 receptorov 

Charakteristika 

Famotidín znižuje tvorbu kyseliny chlorovodíkovej a tráviaceho enzýmu pepsínu v žalúdku a  

znižuje ich obsah v žalúdku. Tým chráni žalúdok a dvanástnik pred vplyvmi, ktoré sa 

významne podieľajú na vzniku a trvaní žalúdočného a dvanástnikového vredu.  

Indikácie 

Prípravok sa užíva : 

- pri žalúdočnom a dvanástnikovom vrede, 

- pri stavoch, ktoré vyžadujú zníženie tvorby žalúdočnej kyseliny (refluxná ezofagitída,   

krvácanie zo žalúdka), 

- pri zvýšenej tvorbe žalúdočnej šťavy napr. pri Zollinger-Ellisonovom syndróme, 

- pri prevencii opakovania žalúdočného alebo dvanástnikového vredu. 

Prípravok môžu užívať dospelí a mladiství. 

Kontraindikácie  

Prípravok sa nesmie užívať pri precitlivenosti na famotidín a pomocné látky prípravku. 

Pre podávanie prípravku deťom musia byť obzvlášť závažné dôvody. 

Tehotenstvo a dojčenie. 

Prípravok sa nemá užívať počas tehotenstva a dojčenia. 

Ak sa stavy uvedené v tomto odseku u vás vyskytnú až počas užívania prípravku, informujte 

o tom svojho ošetrujúceho lekára. 

Nežiaduce účinky 

Prípravok sa zvyčajne dobre  toleruje. Ojedinele sa môžu vyskytnúť bolesti hlavy, únava, 

hnačka, zriedkavo zápcha, pocit nevoľnosti a vracanie, plynatosť, znížená chuť do jedla, 

vyrážky, výnimočne po vysokých dávkach srdcová slabosť a spomalenie srdcového rytmu.  

Pri prípadnom výskyte nežiaducich účinkov alebo iných nezvyčajných reakcií sa o ďalšom 

užívaní prípravku  poraďte s lekárom. 

Interakcie                                                                                                                               

Účinky prípravku Famotidin 20-SL a Famotidin 40-SL a iných súčasne užívaných liekov sa 

môžu navzájom ovplyvňovať. Váš lekár by preto mal byť informovaný o všetkých liekoch, 

ktoré v súčasnosti užívate alebo ktoré začnete užívať, a to na lekársky predpis i bez neho. 

Famotidin 20-SL a Famotidin 40-SL môže znížiť účinnosť liečiv, ktorých pôsobenie závisí od 

kyslého žalúdočného prostredia, napr. prípravky s účinnou látkou  sukralfát. 

     

Dávkovanie 

Presné dávkovanie a dĺžku liečby určí lekár. 

Pri dvanástnikovom a žalúdočnom vrede sa zvyčajne užíva 1 tableta Famotidinu 40–SL alebo 

2 tablety Famotidinu 20-SL 1x denne večer alebo pred spaním. Dĺžka liečby trvá podľa 

potreby  4-8 týždňov, pri žalúdočnom vrede zvyčajne do inštrumentálneho overenia zhojenia 

vredu lekárom. 

Pri zvýšenej tvorbe žalúdočnej kyseliny (Zollinger-Ellisonov syndróm) je počiatočná dávka  

1 tableta Famotidinu 20-SL každých 6 hodín, potom lekár môže upraviť dávky  podľa potreby 

až na 480 mg denne. Prípravok sa v tejto indikácii užíva dlhodobo, aj  1 rok.  

Pri refluxnej ezofagitíde sa zvyčajne užíva 1 tableta Famotidin 20-SL 2x denne ráno a večer 

po dobu 6-12 týždňov. 

Preventívne proti návratu  niektorého z vyššie uvedených ochorení  sa zvyčajne podáva 1 

tableta Famotidinu 20-SL 1x denne pred spaním.   

Pacienti s poruchou funkcie obličiek - lekár podľa miery poruchy upraví dávkovanie, 

zvyčajne na dávku 1x1 tableta Famotidin 20-SL  denne. 

Spôsob podávania 

Prípravok sa užíva s jedlom alebo nezávisle od jedla, zapíja sa dostatočným množstvom 

tekutiny. 

Upozornenie 

Predávkovanie                                     

Pri predávkovaní alebo náhodnom užití väčšieho množstva prípravku  dieťaťom sa poraďte 

s lekárom. 

Varovanie 

Prípravok nepoužívajte po uplynutí doby použiteľnosti vyznačenej na obale. 

Balenie 

30 tabliet s obsahom 20 mg 

10 tabliet s obsahom 40 mg 

Uchovávanie 

Prípravok uchovávajte  v suchu pri teplote 15 až 25 °C, chráňte pred svetlom. 

Prípravok uchovávajte mimo dosahu detí. 

Dátum poslednej revízie  

 máj 1999                                                                                                           

9-4-2018

Club 13 Recalls Kratom Maeng Da Red Powder and Capsules Because of Possible Health Risk

Club 13 Recalls Kratom Maeng Da Red Powder and Capsules Because of Possible Health Risk

Club 13 of St. Augustine, FL is recalling 15-gram, 30-gram, 90-gram, 150-gram, and 454-gram pouches, and all bulk orders of "Maeng Da Red" kratom powder; and 5-count, 25-count, 50-count, 100-count, 120-count capsule, and all bulk capsule orders of “Maeng Da Red” kratom bottles; and 5-count, 20-count, 25-count, 40-count, 50-count capsule “Maeng Da Red XS” kratom bottles because they have the potential to be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections i...

FDA - U.S. Food and Drug Administration

18-4-2018

A-20 (Beef, Pork, Lamb, Chicken, And Turkey) Solution [DNA Labs, Inc.]

A-20 (Beef, Pork, Lamb, Chicken, And Turkey) Solution [DNA Labs, Inc.]

Updated Date: Apr 18, 2018 EST

US - DailyMed

18-4-2018

FAMOTIDINE Tablet, Film Coated [RedPharm Drug, Inc.]

FAMOTIDINE Tablet, Film Coated [RedPharm Drug, Inc.]

Updated Date: Apr 18, 2018 EST

US - DailyMed

17-4-2018

Adverse Pregnancy Outcomes More Likely With Hypertension History

Adverse Pregnancy Outcomes More Likely With Hypertension History

Women with a history of chronic hypertension are three to five times more likely to have a poor pregnancy outcome than women without past hypertension, even if their blood pressure is normal before 20 weeks gestation, found a retrospective cohort study published April 6 in Obstetrics & Gynecology.

US - RxList

11-4-2018

HEARTBURN RELIEF ORIGINAL STRENGTH (Famotidine) Tablet [Proficient Rx LP]

HEARTBURN RELIEF ORIGINAL STRENGTH (Famotidine) Tablet [Proficient Rx LP]

Updated Date: Apr 11, 2018 EST

US - DailyMed

11-4-2018

FAMOTIDINE Tablet, Film Coated [REMEDYREPACK INC.]

FAMOTIDINE Tablet, Film Coated [REMEDYREPACK INC.]

Updated Date: Apr 11, 2018 EST

US - DailyMed

10-4-2018

Sunburn (Sun Poisoning)

Sunburn (Sun Poisoning)

Title: Sunburn (Sun Poisoning)Category: Diseases and ConditionsCreated: 8/20/2008 12:00:00 AMLast Editorial Review: 4/10/2018 12:00:00 AM

US - MedicineNet

30-3-2018

TRIMOL (Ichthammol 20%) Salve [Trifecta Pharmaceuticals USA LLC]

TRIMOL (Ichthammol 20%) Salve [Trifecta Pharmaceuticals USA LLC]

Updated Date: Mar 30, 2018 EST

US - DailyMed

28-3-2018

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (Active substance: Sodium (1R,3R,4R,5S)-3-({2-N-acetylamino-2-deoxy-3-O-[(1S)-1-carboxylato-2-cyclohexylethyl]-beta-D-galactopyranosyl}oxy)-4-({6-deoxy-alpha-L-galactopyranosyl}oxy)-5-ethyl-cyclohexan-1-yl-(38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carboxamide) - Transfer of orphan designation - Commission Decision (2018)2011 of Wed, 28 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/010/17/T/01

Europe -DG Health and Food Safety

23-3-2018

GLIZIGEN GEL INTIMATE (Glycerin) Gel [Catalysis, SL]

GLIZIGEN GEL INTIMATE (Glycerin) Gel [Catalysis, SL]

Updated Date: Mar 23, 2018 EST

US - DailyMed

22-3-2018

Task Force Issues Stronger Skin Cancer Prevention Guidelines

Task Force Issues Stronger Skin Cancer Prevention Guidelines

Title: Task Force Issues Stronger Skin Cancer Prevention GuidelinesCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

Mississippi Bans Abortions After 15 Weeks' Gestation

Mississippi Bans Abortions After 15 Weeks' Gestation

Title: Mississippi Bans Abortions After 15 Weeks' GestationCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

Are Pricey Orthotic Insoles Worth It for Heel Pain?

Are Pricey Orthotic Insoles Worth It for Heel Pain?

Title: Are Pricey Orthotic Insoles Worth It for Heel Pain?Category: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

School Nurses at Ground Zero for Food Allergies

School Nurses at Ground Zero for Food Allergies

Title: School Nurses at Ground Zero for Food AllergiesCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

Adcetris Approval Expanded to Include Later-Stage Hodgkin Lymphoma

Adcetris Approval Expanded to Include Later-Stage Hodgkin Lymphoma

Title: Adcetris Approval Expanded to Include Later-Stage Hodgkin LymphomaCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

FDA Takes Aim at Flavored Tobacco

FDA Takes Aim at Flavored Tobacco

Title: FDA Takes Aim at Flavored TobaccoCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

Too Much Facebook, Instagram Could Be Tough on Girls

Too Much Facebook, Instagram Could Be Tough on Girls

Title: Too Much Facebook, Instagram Could Be Tough on GirlsCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

Red and Processed Meats Linked to Liver Woes

Red and Processed Meats Linked to Liver Woes

Title: Red and Processed Meats Linked to Liver WoesCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

22-3-2018

Mom's Pre-Pregnancy Waist Size Tied to Autism Risk

Mom's Pre-Pregnancy Waist Size Tied to Autism Risk

Title: Mom's Pre-Pregnancy Waist Size Tied to Autism RiskCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/21/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Range of Vaginal Dryness Products Can Help Postmenopausal Women: Study

Range of Vaginal Dryness Products Can Help Postmenopausal Women: Study

Title: Range of Vaginal Dryness Products Can Help Postmenopausal Women: StudyCategory: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

A Surgery-Free Fix for Bad Knees?

A Surgery-Free Fix for Bad Knees?

Title: A Surgery-Free Fix for Bad Knees?Category: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

The High Costs of Alzheimer's

The High Costs of Alzheimer's

Title: The High Costs of Alzheimer'sCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Women May Dismiss Subtle Warning Signs of Heart Disease

Women May Dismiss Subtle Warning Signs of Heart Disease

Title: Women May Dismiss Subtle Warning Signs of Heart DiseaseCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Cutting Out Late Night Calories

Cutting Out Late Night Calories

Title: Cutting Out Late Night CaloriesCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Stem Cell Transplant Successful in Macular Degeneration Patients: Study

Stem Cell Transplant Successful in Macular Degeneration Patients: Study

Title: Stem Cell Transplant Successful in Macular Degeneration Patients: StudyCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Male Birth Control Pill Shows Early Promise

Male Birth Control Pill Shows Early Promise

Title: Male Birth Control Pill Shows Early PromiseCategory: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Kids With Severe Brain Injuries May Develop ADHD: Study

Kids With Severe Brain Injuries May Develop ADHD: Study

Title: Kids With Severe Brain Injuries May Develop ADHD: StudyCategory: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Facebook May Be 'Safe' Social Space for Adults With Autism

Facebook May Be 'Safe' Social Space for Adults With Autism

Title: Facebook May Be 'Safe' Social Space for Adults With AutismCategory: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Stem Cell Transplant for MS Shows Promise

Stem Cell Transplant for MS Shows Promise

Title: Stem Cell Transplant for MS Shows PromiseCategory: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

When Is a Sick Fellow Flier a Health Risk to You?

When Is a Sick Fellow Flier a Health Risk to You?

Title: When Is a Sick Fellow Flier a Health Risk to You?Category: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Majority of U.S. Adults Have Poor Heart Health: Study

Majority of U.S. Adults Have Poor Heart Health: Study

Title: Majority of U.S. Adults Have Poor Heart Health: StudyCategory: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Booze Boosts Your Heart Rate

Booze Boosts Your Heart Rate

Title: Booze Boosts Your Heart RateCategory: Health NewsCreated: 3/19/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Health Tip: What Could Be Behind Achilles Tendinitis

Health Tip: What Could Be Behind Achilles Tendinitis

Title: Health Tip: What Could Be Behind Achilles TendinitisCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

Health Tip: How You May Benefit From a Standing Desk

Health Tip: How You May Benefit From a Standing Desk

Title: Health Tip: How You May Benefit From a Standing DeskCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

21-3-2018

A Husband's Housework May Bring Bedroom Benefits

A Husband's Housework May Bring Bedroom Benefits

Title: A Husband's Housework May Bring Bedroom BenefitsCategory: Health NewsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

20-3-2018

Agenda:  Agenda - PDCO agenda of the 20-23 March 2018 meeting

Agenda: Agenda - PDCO agenda of the 20-23 March 2018 meeting

Europe - EMA - European Medicines Agency

20-3-2018

Zomarist (Novartis Europharm Limited)

Zomarist (Novartis Europharm Limited)

Zomarist (Active substance: vildagliptin / metformin hydrochloride) - Centralised - Yearly update - Commission Decision (2018)1747 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Mircera (Roche Registration GmbH)

Mircera (Roche Registration GmbH)

Mircera (Active substance: methoxy polyethylene glycol-epoetin beta) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1741 of Tue, 20 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/739/T/66

Europe -DG Health and Food Safety

20-3-2018

Cotellic (Roche Registration GmbH)

Cotellic (Roche Registration GmbH)

Cotellic (Active substance: cobimetinib) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1740 of Tue, 20 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3960/T/11

Europe -DG Health and Food Safety

20-3-2018

Xeloda (Roche Registration GmbH)

Xeloda (Roche Registration GmbH)

Xeloda (Active substance: capecitabine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1739 of Tue, 20 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/316/T/76

Europe -DG Health and Food Safety

20-3-2018

Kinzalkomb (Bayer Pharma AG)

Kinzalkomb (Bayer Pharma AG)

Kinzalkomb (Active substance: Telmisartan / hydrochlorothiazide) - Centralised - Yearly update - Commission Decision (2018)1743 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Integrilin (Glaxo Group Ltd)

Integrilin (Glaxo Group Ltd)

Integrilin (Active substance: Eptifibatide) - Centralised - Yearly update - Commission Decision (2018)1742 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Kadcyla (Roche Registration GmbH)

Kadcyla (Roche Registration GmbH)

Kadcyla (Active substance: Trastuzumab emtansine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1754 of Tue, 20 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2389/T/38

Europe -DG Health and Food Safety

20-3-2018

Avastin (Roche Registration GmbH)

Avastin (Roche Registration GmbH)

Avastin (Active substance: bevacizumab) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1752 of Tue, 20 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/582/T/100

Europe -DG Health and Food Safety

20-3-2018

Aripiprazole Sandoz (Sandoz GmbH)

Aripiprazole Sandoz (Sandoz GmbH)

Aripiprazole Sandoz (Active substance: Aripiprazole) - Centralised - Yearly update - Commission Decision (2018)1753 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Jentadueto (Boehringer Ingelheim International GmbH)

Jentadueto (Boehringer Ingelheim International GmbH)

Jentadueto (Active substance: linagliptin/metformin hydrochloride) - Centralised - Yearly update - Commission Decision (2018)1748 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Vaniqa (Almirall, S.A.)

Vaniqa (Almirall, S.A.)

Vaniqa (Active substance: eflornithine) - Centralised - Yearly update - Commission Decision (2018)1749 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Herceptin (Roche Registration Limited)

Herceptin (Roche Registration Limited)

Herceptin (Active substance: trastuzumab) - Centralised - Yearly update - Commission Decision (2018)1746 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Glyxambi (Boehringer Ingelheim International GmbH)

Glyxambi (Boehringer Ingelheim International GmbH)

Glyxambi (Active substance: empagliflozin/linagliptin) - Centralised - Yearly update - Commission Decision (2018)1744 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

20-3-2018

Sacroiliac Joint Dysfunction (SI Joint Pain)

Sacroiliac Joint Dysfunction (SI Joint Pain)

Title: Sacroiliac Joint Dysfunction (SI Joint Pain)Category: Diseases and ConditionsCreated: 10/31/2007 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

20-3-2018

Reflux Laryngitis (Diet, Home Remedies, Medicine)

Reflux Laryngitis (Diet, Home Remedies, Medicine)

Title: Reflux Laryngitis (Diet, Home Remedies, Medicine)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

20-3-2018

Schatzki Ring (Schatzki's) Causes, Symptoms, and Natural Treatments

Schatzki Ring (Schatzki's) Causes, Symptoms, and Natural Treatments

Title: Schatzki Ring (Schatzki's) Causes, Symptoms, and Natural TreatmentsCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

20-3-2018

Proton Pump Inhibitors vs. Zantac

Proton Pump Inhibitors vs. Zantac

Title: Proton Pump Inhibitors vs. ZantacCategory: MedicationsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

20-3-2018

Torn ACL (Anterior Cruciate Ligament Tear)

Torn ACL (Anterior Cruciate Ligament Tear)

Title: Torn ACL (Anterior Cruciate Ligament Tear)Category: Diseases and ConditionsCreated: 11/4/2010 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

20-3-2018

Scoliosis

Scoliosis

Title: ScoliosisCategory: Diseases and ConditionsCreated: 8/30/1999 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet

20-3-2018

Lichen Sclerosus

Lichen Sclerosus

Title: Lichen SclerosusCategory: Diseases and ConditionsCreated: 7/13/2007 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM

US - MedicineNet